The Scharp –Lacy Institute replaces the Invenio Institute and takes control of its contract with the JDRF to supply human islets for research to its funded investigators.

Invenio Institute has decided to change its name to The Scharp-Lacy Research Institute to capture the research energy and productivity that resulted from the many years of collaborative research between Paul Lacy, MD, PhD and David Scharp, MD while at the Washington University School of Medicine in St. Louis, MO. It is with their spirit of collaborative effort and ongoing creativity that the Institute will move forward to create a similar environment for diabetes research.